Recent investment activity

KANDO id: 14396353

Corporate information

Funding rounds

Actual initial investment stage

Investment activity status
Active investor

Selected investments

Displaying 1 - 1 of 1
Profile Country Date Funding
Avanir Pharmaceuticals Inc A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. Acquisition Initial investment led the round USD 3,500,000,000 (USD 3,500,000,000)

Current team

Past employees

Selected Products / Customers

Financials